Evidence map›Paper›PMID 36233532›Full record

ReviewJournal of clinical medicine2022

Short- and Long-Term Effect of Cochlear Implantation on Disabling Tinnitus in Single-Sided Deafness Patients: A Systematic Review.

Samar A Idriss, Pierre Reynard, Mathieu Marx, Albane Mainguy, Charles-Alexandre Joly, Eugen Constant Ionescu, Kelly K S Assouly, Hung Thai-Van

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pentoxifylline uses in inner ear diseases.European journal of clinical pharmacology · 2025
    Pooled it
  2. Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Samar A IdrissDepartment of Audiology and Otoneurological Evaluation, Edouard Herriot Hospital, Hospices Civils de Lyon, 69002 Lyon, France.ORCID 0000-0001-7782-0005
Pierre ReynardDepartment of Audiology and Otoneurological Evaluation, Edouard Herriot Hospital, Hospices Civils de Lyon, 69002 Lyon, France.ORCID 0000-0001-5901-4392
Mathieu MarxDepartment of Otology, Otoneurology and Pediatric Otolaryngology, Pierre-Paul Riquet Hospital, Toulouse Purpan University Hospital, 31300 Toulouse, France.
Albane MainguyNational Commission for the Evaluation of Medical Devices and Health Technologies, Haute Autorité de Santé, 93210 La Plaine St Denis, France.
Charles-Alexandre JolyDepartment of Audiology and Otoneurological Evaluation, Edouard Herriot Hospital, Hospices Civils de Lyon, 69002 Lyon, France.
Eugen Constant IonescuDepartment of Audiology and Otoneurological Evaluation, Edouard Herriot Hospital, Hospices Civils de Lyon, 69002 Lyon, France.
Kelly K S AssoulyDepartment of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-2667-9499
Hung Thai-VanDepartment of Audiology and Otoneurological Evaluation, Edouard Herriot Hospital, Hospices Civils de Lyon, 69002 Lyon, France.
Université Claude Bernard Lyon 1 · FRHoly Spirit University of Kaslik · LBInserm · FRTechnologies pour la Santé · FRUniversité Toulouse III - Paul Sabatier · FRUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with single-sided deafness can experience an ipsilateral disabling tinnitus that has a major impact on individuals' social communication and quality of life. Cochlear implants appear to be superior to conventional treatments to alleviate tinnitus in single-sided deafness. We conducted a systematic review to evaluate the effectiveness of cochlear implants in single-sided deafness with disabling tinnitus when conventional treatments fail to alleviate tinnitus (PROSPERO ID: CRD42022353292). All published studies in PubMed/MEDLINE and SCOPUS databases until December 2021 were included. A total of 474 records were retrieved, 31 studies were included and were divided into two categories according to whether tinnitus was assessed as a primary complaint or not. In all studies, cochlear implantation, evaluated using subjective validated tools, succeeded in reducing tinnitus significantly. Objective evaluation tools were less likely to be used but showed similar results. A short-(3 months) and long-(up to 72 months) term tinnitus suppression was reported. When the cochlear implant is disactivated, complete residual tinnitus inhibition was reported to persist up to 24 h. The results followed a similar pattern in studies where tinnitus was assesed as a primary complaint or not. In conclusion, the present review confirmed the effectiveness of cochlear implantation in sustainably reducing disabling tinnitus in single-sided deafness patients.

Indexed as

cochlear implantdisabling tinnitushyperacusisquality of lifesingle-sided deafnesssound localizationspeech perceptionsystematic review

Identifiers

PMID36233532
PMCPMC9572534
OpenAlexW4297540993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.